Literature DB >> 34117855

Advances on molecular mechanism of hepatitis B virus-induced hepatocellular carcinoma.

Yiming Shao1, Lide Su1, Rui Hao1, Qianqian Wang1, Hua Naranmandura1.   

Abstract

The pathogenesis of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is complicated with the crosstalk of multiple factors and the multi-step processes. The main mechanisms underlying the HBV-induced HCC include:①integration of HBV DNA into the host hepatocyte genome to alter gene function at the insertion site,resulting in host genome instability and expression of carcinogenic truncated proteins;②HBV gene mutations at S,C,and X coding regions in the genome;③HBV X gene-encoded HBx protein activates proto-oncogenes and inhibits tumor suppressor genes,leading to the HCC occurrence. In this article,the recent research progress on the molecular mechanism of HBV-induced HCC is comprehensively reviewed,so as to provide insights into the prevention,early prediction and postoperative adjuvant therapy of HCC.

Entities:  

Keywords:  Gene integration; Gene mutation; Hepatitis B virus; Hepatitis B virus X protein; Hepatocellular carcinoma; Review

Mesh:

Year:  2021        PMID: 34117855      PMCID: PMC8675070          DOI: 10.3724/zdxbyxb-2021-0032

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  58 in total

1.  Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma.

Authors:  Wit Thun Kwa; Kathryn Effendi; Ken Yamazaki; Naoto Kubota; Mami Hatano; Akihisa Ueno; Yohei Masugi; Michiie Sakamoto
Journal:  Pathol Int       Date:  2020-06-19       Impact factor: 2.534

2.  Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.

Authors:  Minjie Wang; Yuting Wang; Xiaoshuang Feng; Ruijun Wang; Yanmei Wang; Hongmei Zeng; Jun Qi; Hong Zhao; Ni Li; Jianqiang Cai; Chunfeng Qu
Journal:  Int J Infect Dis       Date:  2017-09-19       Impact factor: 3.623

3.  Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.

Authors:  Chiao-Ling Li; Chen-Yu Li; You-Yu Lin; Ming-Chih Ho; Ding-Shinn Chen; Pei-Jer Chen; Shiou-Hwei Yeh
Journal:  Hepatology       Date:  2019-01-16       Impact factor: 17.425

4.  Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells.

Authors:  Nan You; Weihui Liu; Lijun Tang; Xiao Zhong; Ru Ji; Ning Zhang; Desheng Wang; Yong He; Kefeng Dou; Kaishan Tao
Journal:  J Exp Clin Cancer Res       Date:  2012-09-13

5.  Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.

Authors:  G Wu; F Yu; Z Xiao; K Xu; J Xu; W Tang; J Wang; E Song
Journal:  Br J Cancer       Date:  2011-05-31       Impact factor: 7.640

6.  Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma.

Authors:  Chih-Ming Lin; Gen-Ming Wang; Guey-Mei Jow; Bing-Fang Chen
Journal:  J Biomed Sci       Date:  2012-02-07       Impact factor: 8.410

Review 7.  Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.

Authors:  Francesca Pezzuto; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Infect Agent Cancer       Date:  2017-05-19       Impact factor: 2.965

Review 8.  The Mechanism of MAPK Signal Transduction Pathway Involved with Electroacupuncture Treatment for Different Diseases.

Authors:  Weibin Du; Huahui Hu; Jiangsong Zhang; Guanai Bao; Rongliang Chen; Renfu Quan
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-31       Impact factor: 2.629

9.  Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.

Authors:  Serena Nik-Zainal; David C Wedge; Ludmil B Alexandrov; Mia Petljak; Adam P Butler; Niccolo Bolli; Helen R Davies; Stian Knappskog; Sancha Martin; Elli Papaemmanuil; Manasa Ramakrishna; Adam Shlien; Ingrid Simonic; Yali Xue; Chris Tyler-Smith; Peter J Campbell; Michael R Stratton
Journal:  Nat Genet       Date:  2014-04-13       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.